Streetbeat News

Earnings

ACON

AGTI

AKLI

LUNR

PPC

TRNR

VERO

Pilgrim's Pride Corporation (NASDAQ:PPC) reported better-than-expected Q4 results with a 9.7% year-over-year sales growth to $4.528 billion and an adjusted EPS of 59 cents. Akili, Inc. (NASDAQ:AKLI) shares surged 116% after positive ADHD treatment trial results. Interactive Strength Inc. (NASDAQ:TRNR) rose 41% on a distribution deal with WOODWAY. Agiliti, Inc. (NYSE:AGTI) gained 29% after announcing a private acquisition by THL Partners. Aclarion, Inc. (NASDAQ:ACON), Intuitive Machines, Inc. (NASDAQ:LUNR), and Venus Concept Inc. (NASDAQ:VERO) saw significant share price drops due to various challenges.

Portfolio Pulse from Avi Kapoor

February 26, 2024 | 7:30 pm

SPRY

ARS Pharmaceuticals Inc (NASDAQ:SPRY) announced positive phase 2 results for its lead candidate, neffy, in treating chronic spontaneous urticaria, showing significant improvements in itch, hives, urticaria, and erythema scores. Neffy, an epinephrine nasal spray, was well-tolerated with mild to moderate adverse events. The company plans further studies towards FDA approval for allergic reactions, including anaphylaxis, with SPRY shares rising 5.15% to $8.78.

Portfolio Pulse from Vandana Singh

February 26, 2024 | 7:12 pm

AMEH

Apollo Medical Holdings (NASDAQ:AMEH) is scheduled to release its quarterly earnings report on February 27, 2024. Analysts predict an EPS of $0.15. The company's past performance shows a pattern of beating EPS estimates, leading to positive stock price movements. Shares are currently trading at $40.82, with a 16.96% increase over the last year. Investors are optimistic but will focus on the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 7:02 pm

IMAX

Imax (NYSE:IMAX) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts expecting an EPS of $0.05. The company's past performance shows a trend of beating EPS estimates, which has positively impacted its share price. However, shares have declined by 14.18% over the last 52 weeks, indicating a bearish outlook among long-term shareholders. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 7:02 pm

INSE

Inspired Entertainment (NASDAQ:INSE) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts estimating an EPS of $0.38. The company's past earnings performance shows mixed results, with a miss last quarter but a subsequent share price increase. Over the last year, INSE shares have declined by 36.34%. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 7:02 pm

PNW

Pinnacle West Capital (NYSE:PNW) is expected to report a Q4 EPS of $-0.13 on February 27, 2024. Analysts and investors are looking for an earnings beat and positive guidance for the next quarter. The company's past earnings performance shows mixed results with both beats and misses, affecting stock prices variably. Shares are currently trading at $70.5, down 6.49% over the last year, indicating a cautious outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 7:02 pm

PAR

PAR Technology (NYSE:PAR) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts expecting an EPS of $-0.26. The company's past earnings performance shows a mix of beats and misses, with the last quarter beating estimates by $0.14, leading to a 9.27% share price increase the following day. Shares are currently trading at $46.27, up 35.95% over the last 52 weeks, indicating a positive sentiment among long-term shareholders ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 7:01 pm

TARS

Tarsus Pharmaceuticals (NASDAQ:TARS) is scheduled to release its quarterly earnings report on February 27, 2024, with an expected EPS of $-1.36. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historically, TARS has shown a mixed performance in beating EPS estimates, with a notable 12.2% share price increase following last quarter's earnings beat. Shares are currently trading at $31.7, reflecting a 111.04% increase over the last 52 weeks, indicating a positive outlook among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 7:01 pm

STGW

Stagwell (NASDAQ:STGW) is scheduled to release its quarterly earnings report on February 27, 2024, with an estimated EPS of $0.27. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Stagwell's past earnings performance shows a mixed record of beating and missing EPS estimates, with corresponding fluctuations in stock price. Shares are currently trading at $6.92, reflecting a 1.68% increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 7:01 pm

EYE

National Vision Holdings (NASDAQ:EYE) is scheduled to release its quarterly earnings report on February 27, 2024, with an expected EPS of $-0.09. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows that EYE's stock price reacts more significantly to guidance than to earnings beats or misses. In the last quarter, EYE beat the EPS estimate by $0.06, leading to a 6.29% increase in its stock price the following day. However, over the last 52 weeks, EYE shares have declined by 45.12%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 7:01 pm